4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-24-000162
Chief Accounting Officer sold 201 shares at $15.32 ($3,079)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Azoy Alexander · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-02 | Sale : show line 1 in the form 10b5-1 | −201 | $15.32 | $3,079 | 19,070 | D |
| Open-market sales · 201 sh · avg $15.32 · $3,079 | ||||||
Loading xslF345X05/wk-form4_1733346648.xml…